US Stock MarketDetailed Quotes

CTSO Cytosorbents

Watchlist
  • 1.100
  • -0.030-2.65%
Close Mar 18 16:00 ET
  • 1.090
  • -0.010-0.91%
Post 19:43 ET
68.58MMarket Cap-3.06P/E (TTM)

About Cytosorbents Company

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.

Company Profile

SymbolCTSO
Company NameCytosorbents
Listing DateDec 23, 2014
Founded1997
CEODr. Phillip P. Chan, M.D.,PhD
MarketNASDAQ
Employees186
Fiscal Year Ends12-31
Address305 College Road East
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-732-329-8885
Websitehttp://cytosorbents.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Phillip P. Chan, M.D.,PhD
  • Chief Executive Officer and Director
  • 1.33M
  • Vincent J. Capponi, M.S.
  • President and Chief Operating Officer
  • 1.11M
  • Peter J. Mariani
  • Chief Financial Officer
  • --
  • Dr. Efthymios Nikolaos Deliargyris, M.D.
  • Chief Medical Officer
  • 1.06M
  • Michael G. Bator
  • Chairman of the Board
  • 161.70K
  • Dr. Edward R. Jones, M.B.A.,M.D.
  • Independent Director
  • 101.93K
  • Alan D. Sobel, C.P.A.
  • Independent Director
  • 118.47K
  • Jiny Kim, M.B.A.
  • Independent Director
  • 101.80K

Trending Stocks

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Dorian LPG
LPG
22.520
YETI Holdings
YETI
34.180
Workday
WDAY
251.910
4
Collegium Pharmaceutical
COLL
29.820
5
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.010
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!